CYCLOBUTYL SUBSTITUTED PYRROLOPYRIDINE AND PYRROLOPYRIMIDINES DERIVATIVES AS JAK INHIBITORS
申请人:Incyte Corporation
公开号:US20150087632A1
公开(公告)日:2015-03-26
The present invention provides cyclobutyl substituted pyrrolopyrimidines and pyrrolopyridines of Formula I:
wherein X, Y, Z, L, A, R
5
, n and m are defined above, as well as their compositions and methods of use, that modulate the activity of Janus kinases (JAKs) and are useful in the treatment of diseases related to the activity of JAKs including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
本发明提供了公式I的环丁基取代的吡咯吡嘧啶和吡咯吡啶化合物:其中X,Y,Z,L,A,R5,n和m如上所定义,以及它们的组合物和使用方法,调节Janus激酶(JAKs)的活性,并且对于治疗与JAKs活性相关的疾病,例如炎症性疾病,自身免疫性疾病,癌症和其他疾病非常有用。